AloeVeritas Announces Preliminary Data from Ongoing Phase 1 Observational Study of AloeMD (a drug-less pain disruptor) Showing Strong Evidence of Significant Results in Participants with Acute and Chronic Pain.
AloeVeritas today announced the call for consumer volunteers in a Phase I study of AloeMD, also known as an extracellular matrix protector and pain disruptor.
AloeVeritas Launched a new patented 100% natural arthritis and joint pain product that not only provides drug free and opioid free relief, but also boosts the body’s own innate intelligence to repair itself.
Following a successful launch in Europe where month-over-month growth exceeded 150%, AloeVeritas will soon bring a holistic plan for wellness to the United States.
